NIH-funded cancer study
This article was originally published in The Tan Sheet
The National Institutes of Health awards Omaha, Neb.-based Creighton University $4 million to continue a "landmark" study linking vitamin D to reduced cancer risk. The original study, headed by Joan Lappe and reported in June 2007, showed for the first time in a clinical setting that postmenopausal women consuming calcium and vitamin D3 supplements at nearly three times the recommended levels could reduce the risk of cancer by 60-77 percent, the university says Jan. 26. "We must now confirm these findings with a clinical trial specifically designed to look at calcium, vitamin D and cancer," Lappe says. "Confirmation is necessary in order to have evidence solid enough to change public policy regarding intake levels for vitamin D." The four-year study begins in April and will follow 2,300 healthy, postmenopausal women from Nebraska
You may also be interested in...
October and November 2020 were bad months for companies seeking to have their planned EU filings fast-tracked through the centralized drug review system at the European Medicines Agency.
Tactic aims to allow incoming Administration to scrutinize so-called ‘midnight rules’ issued in the final days of the Trump Administration before they take effect. Regulators may also solicit stakeholder comments on delayed rules.
Device companies operating in Canada are being advised to review their internal procedures in anticipation of new postmarket requirements that come into force this year.